Development of a Multiparametric Voxel-Based Magnetic Resonance Imaging Biomarker for Early Cancer Therapeutic Response Assessment.

Authors:
Galbán CJ; Lemasson B; Hoff BA; Johnson TD; Sundgren PC and 3 more

Journal:
Tomography

Publication Year: 2015

DOI:
10.18383/j.tom.2015.00124

PMCID:
PMC4643274

PMID:
26568982

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Tomography

Abbreviation: Tomography

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Diagnostic Imaging

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Accelerated Hypofractionated Magnetic Resonance Guided Adaptive Radiation Therapy for Ultracentral …
La Rosa A; Mittauer KE; Bassiri N and 10 more (2024) - Transparency Score: 3/6
Differential Assessment of Internal Jugular Vein Stenosis in Patients Undergoing CT and MRI with Co…
Abdalkader M; Miller MI; Klein P and 6 more (2024) - Transparency Score: 3/6
Differentiation of Hamartomas and Malignant Lung Tumors in Single-Phased Dual-Energy Computed Tomog…
Winkelmann MT; Gassenmaier S; Walter SS and 3 more (2024) - Transparency Score: 3/6
Feasibility of Low-Dose and Low-Contrast Media Volume Approach in Computed Tomography Cardiovascula…
Ippolito D; Porta M; Maino C and 9 more (2024) - Transparency Score: 3/6
Lumbar Disc Degeneration Is Linked to Dorsal Subcutaneous Fat Thickness at the L1-L2 Intervertebral…
Kanbayti IH; Al-Buqami AS; Alsheikh MH and 5 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest: Patents from the University of Michigan have been licensed to Imbio, LLC, in which B.D.R. has an ownership interest. B.D.R., T.L.C., and C.J.G. also have a financial interest in the underlying PRM technology licensed to Imbio, LLC."

Evidence found in paper:

"This work was supported by National Institutes of Health research grants P01CA085878 and U01CA166104 and Swedish Cancer Foundation grant CAN 2013/321. C.J.G. and B.L. contributed equally to this work."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025